Is The Biotech Sector Stuck In A Talent Time-Loop?
This article was originally published in Scrip
Recently Scrip took an in depth look at the lack of female board members and senior executives at pharmaceutical and biotech companies – and the data showed a shocking gender gap at the top of these businesses. Diversity issues for boards of life science companies appear not to be limited to gender inequality, either.
You may also be interested in...
A steady flow of venture capital into the medical device industry continued in the first half of 2020 despite the novel coronavirus pandemic. While Biopharma companies secured more than $7.5bn in private financings between January and June.
Experts discuss the future of brain health, changing the stereotypical view of an Alzheimer’s patient and how technology and science have evolved the treatment possibilities for dementia patients in 2020 – even if ‘clinical practice is taking a long time to catch up.’
A complete response letter from the FDA in June knocked Intercept’s stock price down to 2014 levels, but perhaps the regulator is sending wider messages about NASH.